SPDR S&P Biotech (XBI) 159.21 $XBI
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 2.26% Yesterday
Comtex SmarTrend(R) - Mon Sep 15, 4:55PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $154.86 to a high of $160.44. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $157.12 on volume of 593,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.69% Rise
Comtex SmarTrend(R) - Tue Aug 26, 4:32PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $158.91 to a high of $163.25. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $159.78 on volume of 468,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Aug 26, 12:00PM CDT
The news of InterMune's acquisition by Roche has led to a rally in the biotech ETFs space.
Biotech Stock Boom Times Are Back
at The Street - Tue Aug 26, 6:00AM CDT
The iShares Nasdaq Biotechnology ETF closed at 272.63 Monday, less than one point below the year (and all-time) closing high reached on Feb. 25.
Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks
at The Street - Thu Aug 14, 11:34AM CDT
A month after Fed Chair Janet Yellen's comments, ETFs covering both groups are pushing towards new highs on strong fundamental backdrops.
'Fast Money' Recap: Can You Trust This Rally?
at The Street - Tue Aug 12, 4:00AM CDT
The trading panel discussed whether the Federal Reserve is having more of an effect on the markets than geopolitical events.
'Fast Money' Recap: Is Michael Kors Still in Fashion?
at The Street - Tue Aug 05, 4:00AM CDT
The trading panel looked at Michael Kors' earnings, Microsoft, steel stocks and biotechs.
'Fast Money' Recap: A Game-Changing Twitter Quarter
at The Street - Wed Jul 30, 4:00AM CDT
The trading panel looked at the social media company's earnings, Panera Bread and Spirit Airlines.
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 6.86% Rise
Comtex SmarTrend(R) - Wed Jul 23, 4:35PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $147.64 to a high of $150.99. Yesterday, the shares gained 6.9%, which took the trading range above the 3-day high of $142.31 on volume of 956,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox
at The Street - Fri Jul 18, 6:51AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
After Yesterday's Decline of 3.86%, SPDR S&P Biotech ETF Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 15, 5:08PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $141.01 to a high of $148.07. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $142.38 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
The Zacks Analyst Blog Highlights:iShares Residential Real Estate Capped ETF, First Trust Amex Biotechnology Index Fund, SPDR S&P Biotech ETF, PowerShares Dynamic Semiconductors and SPDR S&P Semiconductor ETF
PR Newswire - Mon Jul 07, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares Residential Real Estate Capped ETF (AMEX:REZ-Free Report), First Trust Amex Biotechnology Index Fund (AMEX:FBT-Free Report), SPDR S&P Biotech ETF (AMEX:XBI-Free Report), PowerShares Dynamic Semiconductors(AMEX
SI-Free Report) and SPDR S&P Semiconductor ETF(AMEX:XSD-Free Report).
3 American ETFs That Saw Fireworks to Start 2014 - ETF News And Commentary
Eric Dutram - ZACKS - Thu Jul 03, 11:00AM CDT
Several US focused ETFs put up gains of at least 20 percent to start 2014.
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 2.26% Yesterday
Comtex SmarTrend(R) - Mon Sep 15, 4:55PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $154.86 to a high of $160.44. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $157.12 on volume of 593,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.69% Rise
Comtex SmarTrend(R) - Tue Aug 26, 4:32PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $158.91 to a high of $163.25. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $159.78 on volume of 468,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Aug 26, 12:00PM CDT
The news of InterMune's acquisition by Roche has led to a rally in the biotech ETFs space.
Biotech Stock Boom Times Are Back
at The Street - Tue Aug 26, 6:00AM CDT
The iShares Nasdaq Biotechnology ETF closed at 272.63 Monday, less than one point below the year (and all-time) closing high reached on Feb. 25.
Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks
at The Street - Thu Aug 14, 11:34AM CDT
A month after Fed Chair Janet Yellen's comments, ETFs covering both groups are pushing towards new highs on strong fundamental backdrops.
'Fast Money' Recap: Can You Trust This Rally?
at The Street - Tue Aug 12, 4:00AM CDT
The trading panel discussed whether the Federal Reserve is having more of an effect on the markets than geopolitical events.
'Fast Money' Recap: Is Michael Kors Still in Fashion?
at The Street - Tue Aug 05, 4:00AM CDT
The trading panel looked at Michael Kors' earnings, Microsoft, steel stocks and biotechs.
'Fast Money' Recap: A Game-Changing Twitter Quarter
at The Street - Wed Jul 30, 4:00AM CDT
The trading panel looked at the social media company's earnings, Panera Bread and Spirit Airlines.
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 6.86% Rise
Comtex SmarTrend(R) - Wed Jul 23, 4:35PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $147.64 to a high of $150.99. Yesterday, the shares gained 6.9%, which took the trading range above the 3-day high of $142.31 on volume of 956,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox
at The Street - Fri Jul 18, 6:51AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
After Yesterday's Decline of 3.86%, SPDR S&P Biotech ETF Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 15, 5:08PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $141.01 to a high of $148.07. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $142.38 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
The Zacks Analyst Blog Highlights:iShares Residential Real Estate Capped ETF, First Trust Amex Biotechnology Index Fund, SPDR S&P Biotech ETF, PowerShares Dynamic Semiconductors and SPDR S&P Semiconductor ETF
PR Newswire - Mon Jul 07, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares Residential Real Estate Capped ETF (AMEX:REZ-Free Report), First Trust Amex Biotechnology Index Fund (AMEX:FBT-Free Report), SPDR S&P Biotech ETF (AMEX:XBI-Free Report), PowerShares Dynamic Semiconductors(AMEX
SI-Free Report) and SPDR S&P Semiconductor ETF(AMEX:XSD-Free Report). 3 American ETFs That Saw Fireworks to Start 2014 - ETF News And Commentary
Eric Dutram - ZACKS - Thu Jul 03, 11:00AM CDT
Several US focused ETFs put up gains of at least 20 percent to start 2014.
